Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-15

Clinical Trial Update: A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) [Phase 3]

View source ↗

Summary

Phase 3 study of an investigational zoster vaccine in subjects with a history of herpes zoster was completed. Results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational Zoster Vaccine (V211-014)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2010-12-15